Allos AI: Valuation, Funding & Investors
Allos AI applies Causal AI to reformulate complex small-molecule drugs by modeling how formulation, dosing, delivery, and patient biology interact to drive clinical outcomes. The company partners with pharmaceutical developers and generic manufacturers to modernize legacy assets, design more interpretable clinical studies using real-world evidence, and advance complex generics and high-risk NCE programs.
Leadership & Board
- Current Number of Employees
- 18
- Current LinkedIn Followers
- 1,186
Latest Estimated Valuation
- Total Amount Raised
- $5M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $5M
- Latest Funding Round
- Seed Round
Employee Trend
Allos AI had 18 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
18Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Allos AI had 1,186 followers as of October 26, 2026. The number of followers increased by 3 (0.25%) week-over-week.
1,186Latest Followers Count
3(0.25%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 12, 2026 | Seed Round | $5.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Oxford Science Enterprises | Seed Round |
| Berkeley SkyDeck | Seed Round |
| Habico Invest | Seed Round |
Similar Companies
A snapshot of private companies similar to Allos AI, helping you discover and navigate related company profiles.
Related News and Analysis
